Optune Lua: a Novel Approach to Treatment for Patients with 2L+ mNSCLC

When:  May 20, 2025 from 18:00 to 20:00 (ET)
Associated with  Central New Jersey

NOVOCURE invites you to a Central NJ ONS meeting about the new use of Optune Lua for mNSCLC patients.

Please come to hear about this exciting approach.  If you've heard NOVOCURE's glioblastoma use of TTfields, this will show you different ways for the fields to be used with lung cancer.

Limited Seating, please RSVP early!

Location

B2 Bistro + Bar
709 Arnold Ave.
Point Pleasant, NJ 08742

Contact

Kellie Blanchard

kblanchard@novocure.com